Baxter reports third-quarter 2024 results

Deerfield, ill.--(business wire)--baxter international inc. (nyse:bax), a global medtech leader, today reported results for the third quarter of 2024. “baxter delivered positive performance in the third quarter of 2024, as the company continues to execute against its strategic transformation,” said josÉ (joe) e. almeida, chair, president and chief executive officer. “the pending sale of our kidney care business represents another defining milestone in our ongoing transformation journey. we are.
BAX Ratings Summary
BAX Quant Ranking